TL;DR - "Math is hard. Colors are pretty! Facts are non-existent."
In actual news, RXMD's revenues are up 15%, and they're well on their way to moving up to OTCQB. They've also engaged a new company promotion firm, which should get lots of new investor eyes on the stock.
If you stick to the facts, RXMD is a bargain, but that won't last for long.